
==== Front
BMJ OpenBMJ OpenbmjopenbmjopenBMJ Open2044-6055BMJ Publishing Group BMA House, Tavistock Square, London, WC1H 9JR bmjopen-2017-016700corr110.1136/bmjopen-2017-016700corr1Correction1506Correction: Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia 2018 8 3 2018 8 3 e016700corr1© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.2018This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/special-featureunlocked
==== Body
Canfell K, Saville M, Caruana M, et al. Protocol for compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia. BMJ Open 2018;8:e016700. doi: 10.1136/bmjopen-2017-016700.

Professor Suzanne Garland was missed out of the original Acknowledgements statement. The Acknowledgements section should read:

Acknowledgments We would like to thank the following associate investigators for their contribution to the Compass trial: Mr David H Wrede, Dr Jeff Tan, Dr Siobhan Bourke, Dr Lara Roeske, Dr Jane Collins, Sandy Anderson and Associate Professor Sally Lord. We would also like to acknowledge the following Scientific Advisory Committee members: Professor Bruce Armstrong, Professor Suzanne Garland, Professor Jonathan Carter, Associate Professor Rachel Skinner, Dr Deborah Bateson, Professor Andrew Grulich, Dr Eduardo Franco, Ms Bridget Whelan (sadly deceased), Associate Professor Annabelle Farnsworth and Ms Susan Taylor. In addition, we would like to acknowledge the following members of the Independent Data Safety and Monitoring Committee: Professor Michael Quinn, Associate Professor Katrina Sharples, Dr Penny Blomfield, Dr Gordon Wright and the secretariat at NHMRC Clinical Trials Centre. Finally, we would like to thank Dr David Hawkes and Ms Chloe Jennett for their contribution to the trial and Dr Louiza S Velentzis for coordinating the authoring of this manuscript.

